FGFR inhibitor
Fibroblast growth factor receptor (FGFR) inhibitors are a class of pharmaceutical agents designed to block the activity of FGFRs, a family of receptor tyrosine kinases involved in cell growth, differentiation, and angiogenesis. Abnormal activation of FGFR signaling pathways has been implicated in various cancers and genetic disorders. FGFR inhibitors function by binding to the ATP-binding pocket of FGFRs, thereby inhibiting their tyrosine kinase activity and subsequent downstream signaling cascades that promote cell proliferation and survival. By blocking FGFRs, these inhibitors aim to halt tumor growth, induce apoptosis in cancer cells, and potentially reduce tumor angiogenesis. Research and clinical trials continue to explore the efficacy and safety of FGFR inhibitors across different cancer types, including those with specific FGFR mutations or amplifications.
- Structure
- Product name
- CAS No.
- Molecular formula
- Inquiry
Total:5 Page 1 of 1 1
![3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea](http://file1.lookchem.com/300w/substances/2022-02-14-05/103363e8-6567-453d-9350-7f4245c68c89.png)